# Ascentage Pharma Group International (ASPHF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ASPHF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 298.09M | ¥ -805.55M | ¥ -610.70M | ¥ 2.09B | ¥ 556.38M |
| 2025 | ¥ 366.74M | ¥ -721.99M | ¥ -1.24B | ¥ 1.98B | ¥ 1.33B |
| 2024 | ¥ 985.41M | ¥ -407.40M | ¥ -136.30M | ¥ 1.67B | ¥ 264.19M |
| 2023 | ¥ 223.28M | ¥ -931.03M | ¥ -776.68M | ¥ 1.80B | ¥ 60.42M |
| 2022 | ¥ 210.32M | ¥ -885.49M | ¥ -859.69M | ¥ 1.79B | ¥ 408.66M |
| 2021 | ¥ 28.49M | ¥ -798.62M | ¥ -1.06B | ¥ 1.08B | ¥ 1.23B |
| 2020 | ¥ 12.89M | ¥ -701.61M | ¥ -890.34M | ¥ 529.70M | ¥ 846.62M |
| 2019 | ¥ 15.07M | ¥ -1.54B | ¥ -558.31M | ¥ 101.41M | ¥ 890.48M |
| 2018 | ¥ 7.38M | ¥ -374.32M | ¥ -273.09M | ¥ 42.04M | ¥ -1.01B |
| 2017 | ¥ 3.63M | ¥ -128.11M | ¥ -150.30M | N/A | N/A |
| 2016 | ¥ 7.87M | ¥ -129.18M | N/A | N/A | N/A |
| 2015 | ¥ 2.16M | ¥ -31.25M | ¥ -13.86M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 3.76 |
| Liabilities / Eq | 4.81 |
| Current Ratio | 1.22 |

## Other views

- [Metrics](https://sponda.capital/en/ASPHF.md)
- [Charts](https://sponda.capital/en/ASPHF/charts.md)
- [Compare](https://sponda.capital/en/ASPHF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.